{"id":61920,"title":"Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.","abstract":"","date":"2014-05-09","categories":"Hemic and Lymphatic Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24652994","annotations":[{"name":"Organ transplantation","weight":0.116613,"wikipedia_article":"http://en.wikipedia.org/wiki/Organ_transplantation"},{"name":"Cell (biology)","weight":0.0805305,"wikipedia_article":"http://en.wikipedia.org/wiki/Cell_(biology)"},{"name":"Roman numerals","weight":0.044168,"wikipedia_article":"http://en.wikipedia.org/wiki/Roman_numerals"},{"name":"Mantle cell lymphoma","weight":0.0342852,"wikipedia_article":"http://en.wikipedia.org/wiki/Mantle_cell_lymphoma"},{"name":"Lymphoma","weight":0.0154274,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymphoma"},{"name":"Nordic countries","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Nordic_countries"},{"name":"Mantle (geology)","weight":0.01376,"wikipedia_article":"http://en.wikipedia.org/wiki/Mantle_(geology)"}]}
